Obesity Another Good Reason to Question the Fixed FEV 1 /FVC Ratio When Diagnosing COPD
For every complex problem, there is a simple solution that is wrong.
G.B. Shaw
To the Editor:
The obesity epidemic does not pass by our (also growing) population of COPD patients. In their recent article in CHEST (August 2011), O'Donnell and coworkers 1 analyzed the lung volumes of adult subjects who visited their lung function laboratory and who suffered from airfl ow obstruction based on the GOLD (Global Initiative for Chronic Obstructive Lung Disease) criterion (postbronchodilator FEV 1 /FVC , 0.7). One of their main conclusions was that the FEV 1 /FVC ratio is strongly infl uenced by the lung-volume-reducing effect of increasing weight. We have found similar results in earlier published data. 2 So, again, we may have a problem with the use of the FEV 1 /FVC ratio to diagnose COPD. Not only will the use of the fi xed (ie, 0.7) value of the FEV 1 /FVC ratio overdiagnose COPD in elderly subjects, 3 it may also underdiagnose the presence of airfl ow obstruction in obese individuals. This is an important fi nding, considering the fact that 29% of O'Donnell's study population was obese.
However, the true magnitude of this problem is likely to be underestimated in the study. The study population consisted of adults who had a postbronchodilator FEV 1 /FVC , 0.7. If increasing weight raises the FEV 1 /FVC ratio, obese subjects are more likely to be wrongly classifi ed as having no airfl ow obstruction and may thus have been underrepresented in the study. This is an important issue for further research.
For clinical practice, the assessment of COPD in obese patients is further complicated by the fact that dyspnea (the key symptom of COPD) may also be caused by carrying excessive body mass. 4 The combination of a higher FEV 1 /FVC ratio and dyspnea that may also be related to obesity may easily result in underdiagnosis of COPD in obese individuals. This could lead to inadequate weight reduction treatment decisions because, according to the obesity paradox, 5 patients with severe COPD may even benefi t from their excessive body mass in terms of survival. Diagnosing COPD is a complex process that is further complicated by comorbid conditions like obesity, and, again, a simplifi ed method of defi ning airfl ow obstruction based on a fi xed ratio (ie, FEV 1 /FVC) seems inadequate. 
Response
We thank Drs van den Bemt and Schermer for their thoughtful comments on our recent article in CHEST 1 on the confounding infl uence of increased body mass on the diagnosis of COPD. Given the dramatic global increases in the prevalence of both obesity and COPD over the past decades, we can no longer neglect the impact of this combination on common pulmonary function measurements and their clinical interpretation. The interaction of COPD and obesity is complex and poorly understood, given the vast pathophysiologic heterogeneity of both conditions. COPD essentially remains a clinical diagnosis based on the triad of smoking (or other noxious gas) exposure, the presence of persistent respiratory symptoms, and the objective demonstration of airfl ow obstruction that is not fully reversible. The defi nition of airway obstruction based on postbronchodilator fi xed FEV 1 /FVC ratio , 0.7 has been criticized because of the risk of overdiagnosis in the elderly and underdiagnosis in the young. 2 , 3 Less attention has been given to the risk of underdiagnosis of COPD in obese smokers by fi xed ratio criteria, given the documented exponential decline in thoracic gas volumes (the denominator) with increasing BMI. 1 , 4 Diagnosis of COPD is further confounded in overweight individuals by uncertainty concerning the specifi c origin of their respiratory symptoms. Thus, activity-related dyspnea in the obese smoker could be explained by factors other than airfl ow obstruction: higher ventilatory demands as a result of higher metabolic requirements of the physical task, skeletal muscle deconditioning due to decreased activity, or increased mechanical loading of the respiratory muscles due to decreased respiratory system compliance. 5 The solution to this complex diagnostic dilemma is not simple. Reliance on a lower limit of normal criteria for FEV 1 /FVC based on population norms (instead of fi xed ratio criteria) may not be the answer because the prevalence of obesity may be underestimated in the existing reference populations from which normative data were derived. Moreover, predictive equations for plethysmographic lung volumes have accounted for the infl uence of age, height, and sex but not of BMI per se. Future prospective population studies are urgently required to better clarify how the presence of obesity affects the diagnosis of COPD.
